AI startups become CFIUS targets when they develop technology with national security implications — advanced AI models, autonomous systems, cybersecurity tools, or dual-use technology that could be adapted for military or intelligence applications. The more the technology intersects with critical infrastructure, sensitive personal data, or defense applications, the more likely any foreign investment will require CFIUS review, regardless of the foreign investor's apparent benign intent.
CFIUS jurisdiction has expanded significantly over the past several years, and the 2026 regulatory landscape reflects a continued tightening of oversight over companies working in artificial intelligence, machine learning, advanced computing, and related technologies. The key statutory category is "TID US businesses" — companies involved in critical technology, critical infrastructure, or sensitive personal data. AI companies developing foundation models, training systems, inference infrastructure, or applications handling large volumes of personal data will almost always qualify. Gurpreet S. Bal notes that this means CFIUS is not an exotic concern for frontier AI labs — it is a routine threshold question for any AI startup accepting investment from non-US persons, even in small amounts.
Investors sometimes fail to disclose CFIUS exposure because they do not understand their own fund's LP composition at the beneficial ownership level, because the disclosure is embarrassing or complicates the investment, or because they assume the startup's counsel will catch the issue. In rolling fund structures and fund-of-funds arrangements, tracing the ultimate source of capital to a covered foreign government or entity requires diligence that not all investors perform on themselves.
Gurpreet S. Bal has a direct answer to this question, grounded in experience: "AI companies have to assume every sophisticated foreign investor has been through a CFIUS review somewhere." Investors — even well-intentioned ones — sometimes omit past CFIUS dealings or foreign ownership ties because they are worried, often correctly, that it will drive off potential co-investors or delay a deal they want to close quickly. In other cases, the investor's LP base includes foreign sovereign wealth funds or foreign institutional investors whose involvement is several layers removed and not immediately visible. In other cases still, a prior portfolio company filed with CFIUS and the investor considers it routine and doesn't think to mention it. The cumulative effect is that founders who rely on voluntary disclosure from investors are not getting the full picture.
Founders should require a representation from every investor that they are not a covered foreign government, that their fund does not have foreign government limited partners above applicable thresholds, and that the investment does not require CFIUS filing. For any investor with potential foreign exposure, founders should request detailed LP disclosure and consult CFIUS counsel before closing. Discovering a CFIUS problem after closing is far more expensive than preventing it.
Gurpreet S. Bal recommends a proactive screening process that doesn't wait for CFIUS to come up. For every significant investor — particularly any with non-US ownership, sovereign-linked capital, or prior investments in dual-use technology companies — the founder's counsel should ask targeted questions early in the process. These include: What is the full ownership and control structure of the fund? Are any limited partners foreign government entities, foreign state-owned enterprises, or nationals of countries covered by CFIUS regulations? Has the fund or any affiliated entity previously been party to a CFIUS mitigation agreement? Has any portfolio company filed voluntarily or received a mandatory referral? The answers to these questions are the minimum required to assess whether a CFIUS filing is necessary — and whether a particular investor is worth the associated complexity.
Closing without a required CFIUS filing exposes the parties to CFIUS jurisdiction to unwind the transaction, require divestiture of the investment, and impose civil monetary penalties. CFIUS can review transactions retroactively with no statute of limitations, meaning an undisclosed covered investment made years ago can resurface during an IPO process or acquisition when the company's investor base is scrutinized. The risk is asymmetric and the penalties can be severe.
The consequences are not theoretical. CFIUS has authority to review transactions retroactively — there is no statute of limitations on the government's ability to investigate a covered transaction that was not filed. If CFIUS reviews a completed transaction and finds that a mandatory filing was required, it can order the parties to remedy the violation, which in the most serious cases means unwinding the investment. For an AI company that has taken foreign capital, built on it, and is now contemplating a major institutional raise or acquisition, discovering a retroactive CFIUS issue can be deal-ending. Gurpreet S. Bal's consistent recommendation is to do the analysis upfront — before the SAFE is signed or the preferred stock subscription agreement is executed — rather than discovering the exposure when you are least able to address it cleanly.
Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com.